Results 201 to 210 of about 28,985 (310)

Preventative Measures for Lower Extremity Skin Conditions in Paralympic and Adaptive Sports: An Epidemiological Overview. [PDF]

Arch Intern Med Res
Wang V, Aabedi A, Agrawal DK.
europepmc   +1 more source

Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru, Nesrine Brahimi, Haleh Zabihi, Cathryn Sibbald, Kyle Seigel, Delaram Shojaei, Eric McMullen, Afsaneh Alavi, Lily Archaempong, Aaron M. Drucker, Adam Weizman, Kenneth Croitoru, Robert Inman, Vincent Piguet   +13 more
wiley   +1 more source

Thoracic Outlet Syndrome Presenting With Unilateral Upper Extremity Venous Congestion: A Diagnostic Role for Dermatology. [PDF]

Cureus
Sayegh A, Fleshner L, Pereira F, Atak MF, Farabi B.   +4 more
europepmc   +1 more source

Impact of Dermatology Consult on Inpatient and Acute Care Management of Hidradenitis Suppurativa

JEADV Clinical Practice, EarlyView.
Natalie Baker, Baraa Hijaz, Allison Holt, Joseph Ebriani, Bethany J. Brumbaugh, Michael Stephens, John Trinidad, Arash Mostaghimi, Daniela Kroshinsky, Steven T. Chen   +9 more
wiley   +1 more source

Patient Characteristics, Disease Profile and Treatment Patterns in Mild and Moderate Psoriasis Patients: Results From Real‐World Clinical Practices in Five European Countries (PROSPECT Study)

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Categorisation of psoriasis (PsO) disease severity in patients varies, although body surface area (BSA) affected is commonly used (< 3% ‘mild’, 3%–10% ‘moderate’ and > 10% ‘severe’). While moderate‐severe PsO has been well‐studied, more limited information regarding mild‐to‐moderate PsO is available.
Emily Goddard, Aaron Keal, James Hetherington, Sophie Barlow, David Wu, Melany Worbes‐Cerezo, Alexander Litvintchouk   +6 more
wiley   +1 more source

Primary care physicians prescribe fewer expensive combination medications than dermatologists for acne: A retrospective review. [PDF]

J Manag Care Spec Pharm
Keime N, Titus O, Ziogaite M, Hugh J, Schilling LM, Dellavalle R, Billups SJ.   +6 more
europepmc   +1 more source

Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos, Line Kibsgaard, Trine Bertelsen   +2 more
wiley   +1 more source

Personalized Approach for Acne Management With Dermocosmetics According to Initial Skin Sensitivity. [PDF]

J Cosmet Dermatol
Han JH, Ju HJ, Kim TI, Yoon YH, Woo YJ, Kye H, Kim JY, Jeong SJ, Baek E, Bae JM.   +9 more
europepmc   +1 more source

Clinical Efficacy and Safety of Topical Roflumilast in Psoriasis: An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Traditional first‐line topical treatments for plaque psoriasis, particularly corticosteroids and vitamin D analogs, frequently have only limited efficacy for long‐term use, and present difficulties with safety and adherence. Objectives In this systematic review and meta‐analysis of randomized controlled trials (RCTs), we assessed ...
Aimal A. Khattak, Ahmed Javed, Ummi Aiman Rahman, Rumaisa Riaz, Zeeshan Imtiaz, Hassan A. Mirza, Farman U. Khan, Muhid Khattak, Fatima Javid, Abdul Moiz Khan, Adeline L. Roy, Bibek Shrestha   +11 more
wiley   +1 more source

Anti-TNF-Related Medium-Vessel Vasculitis: A Report of a Rare Adverse Drug Reaction. [PDF]

Cureus
Hassas Yeganeh M, Malik A, Yaseen A, Zefreh H, Shostak D, Prabhakaran S.   +5 more
europepmc   +1 more source